Clinical utility of polygenic risk scores for predicting NAFLD disorders

J Hepatol. 2021 Apr;74(4):769-770. doi: 10.1016/j.jhep.2021.02.005. Epub 2021 Feb 27.

Author

Alain Dessein¹

Affiliation

¹ GENEPRED Biotechnologies, Bilhigenetics, Marseille, France. Electronic address: alain.dessein@univ-amu.fr.

PMID: 33653592
DOI: 10.1016/j.jhep.2021.02.005

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Genetic Predisposition to Disease
Humans
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / genetics
Risk Factors